Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Samuel Kintz Insider Profile
4 Followers
Samuel Kintz, President & CEO, Director at Enliven Therapeutics, holds 1.26M shares in Enliven Therapeutics (Ticker: ELVN).
Samuel Kintz has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
President & CEO, Director
Roles that Samuel Kintz holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Samuel Kintz
Samuel Kintz's Trading History
List of latest transactions for each holding click on a transaction to see Samuel Kintz's performance on stock
You May Also Like
Samuel Kintz insider profile FAQ
What is the percentage of profitable transactions made by Samuel Kintz?
The percentage of profitable transactions made by Samuel Kintz is ―.
What is the average return per transaction made by Samuel Kintz?
The average return per transaction made by Samuel Kintz is ―.
What stocks does Samuel Kintz hold?
Samuel Kintz holds: ELVN stocks.
What was Samuel Kintz’s latest transaction?
Samuel Kintz latest transaction was an Uninformative Sell of $202.68K.
What was Samuel Kintz's most profitable transaction?
Samuel Kintz’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Samuel Kintz's role in Enliven Therapeutics?
Samuel Kintz's role in Enliven Therapeutics is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.